mannitol has been researched along with Cancer of Head in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Altorjai, G; Fuereder, T; Hecking, M; Herrmann, H; Moll, M; Paschen, C; Widder, J | 1 |
| Cheng, LL; Khuri, FR; Kim, S; McKibbin, T; Owonikoko, TK; Saba, NF; Shin, DM; Steuer, CE | 1 |
| Jahnke, V | 1 |
| Osieka, R; Schmidt, CG | 1 |
| Cvitkovic, E; Golbey, RB; Hayes, DM; Helson, L; Krakoff, IH; Scheiner, E | 1 |
| Dimery, IW; Legha, SS | 1 |
1 review(s) available for mannitol and Cancer of Head
| Article | Year |
|---|---|
[Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)].
Topics: Animals; Cisplatin; Cross Reactions; Cyclophosphamide; DNA, Bacterial; Drug Resistance; Drug Synergism; Head and Neck Neoplasms; Humans; Kidney; Male; Mannitol; Mice; Testicular Neoplasms; Urinary Bladder Neoplasms | 1979 |
1 trial(s) available for mannitol and Cancer of Head
| Article | Year |
|---|---|
Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney Diseases; Male; Mannitol; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Random Allocation; Sodium Chloride | 1986 |
4 other study(ies) available for mannitol and Cancer of Head
| Article | Year |
|---|---|
Effect of mannitol-based reduced-volume hydration on kidney function in concomitant cisplatin-based chemoradiation for head-and-neck squamous cell carcinoma.
Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Female; Head and Neck Neoplasms; Humans; Kidney; Male; Mannitol; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Diuretics, Osmotic; Female; Head and Neck Neoplasms; Humans; Hypokalemia; Kidney Diseases; Magnesium Deficiency; Male; Mannitol; Middle Aged; Neoplasms, Squamous Cell; Retrospective Studies; Sodium Chloride | 2016 |
[Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
Topics: Adult; Aged; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Diuretics; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Mannitol; Methotrexate; Middle Aged | 1980 |
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.
Topics: Adenocarcinoma; Adult; Aged; Cisplatin; Creatinine; Diuresis; Dysgerminoma; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Hearing; Humans; Infusions, Parenteral; Injections, Intravenous; Kidney; Lung Neoplasms; Male; Mannitol; Middle Aged; Neoplasms; Ovarian Neoplasms; Testicular Neoplasms | 1977 |